Summary
Latest filing:
John Martin Docherty is President CSO, Director of Lexaria Bioscience Corp. (LEXX). 1 SEC Form 4 filing on record, dated 29 July 2025. Most recent open-market trade: bought $5K of LEXX on 29 July 2025. Lifetime open-market purchases: $5K.
Recent Transactions
1Every recent SEC Form 4 transaction John Martin Docherty has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as John Martin Docherty. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard Christopher - $132K of LEXX open-market activity on record
- Christopher Bunka - $25K of LEXX open-market activity on record
- William Edward McKechnie - $5K of LEXX open-market activity on record
- Vanessa Carle - $683 of LEXX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is John Martin Docherty?
John Martin Docherty is a corporate insider, tracked as President CSO, Director of Lexaria Bioscience Corp. (LEXX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did John Martin Docherty last file a Form 4?
The only primary Form 4 on record is dated 29 July 2025.
Has John Martin Docherty been buying or selling stock?
Recorded transactions: 1 open-market purchase ($5K) and 0 open-market sales across all tracked filings.
Where can I see all of John Martin Docherty's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow John Martin Docherty and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
